LGALS3 and inflammatory bowel disease: Reduced serum galectin-3 in patients with higher disease activity has been reported by Volarevic et al. [31], but, e.g., Yu et al. did not identify different galectin-3 serum levels of IBD patients with active and inactive disease [34].